>> What are Epiomic™ Epidemiology series reports

What are Epiomic™ Epidemiology series reports

On October 25, 2019,


The epidemiology series reports are a collection of reports which provides a more condensed version of our proprietary Epiomic patient segmentation database. The reports have been developed with our client’s needs, proving a comprehensive overview of the patient populations for a given disease.

Each of the disease publications is specific to a given disease and typically covers between 12-28 Major Global Healthcare Markets with a forecast horizon period of 10 years. Each report includes analyst insights about the disease and or disorder and provides an understanding related to:

  • Cause of the disease
  • Risk factors and prevention
  • Diagnosis of disease
  • Key co-morbid conditions associated with the disease
  • Variations by geography or ethnicity
  • Disease prognosis and clinical course

The entirety of the report is presented in an easy to understand method with data tables presenting prevalence by specific country across a 10-year horizon period. All reports include top-line prevalence of the disease in each country, along with a split by gender. To add more breadth and detail to the report, a breakdown of prevalence or incidence population by gender in 5-year cohorts for each country is included in the appendix section of the report.

The reports also consist of sub-populations that can be either key co-morbid conditions or clinical attributes that assist with size potential of target populations of interest for drug development. All sub-populations are presented in a table format which each population segmented even further by country or other parameters related to the sub-population.

In order to generate accurate patient population estimates, the Epiomic database utilises a combination of world class sources, to provide the most up-to date information from patient registries, clinical trials and epidemiology studies. All sources used to generate the data and analysis have been cited accordingly in the report. 


Rubhaan Malik 

Epidemiology Analyst 

New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic